Viewing StudyNCT05438368



Ignite Creation Date: 2024-05-06 @ 5:47 PM
Last Modification Date: 2024-10-26 @ 2:36 PM
Study NCT ID: NCT05438368
Status: RECRUITING
Last Update Posted: 2022-06-30
First Post: 2022-06-21

Brief Title: GD2CD70 Bi-specific CAR-T Cell Therapy
Sponsor: Shenzhen Geno-Immune Medical Institute
Organization: Shenzhen Geno-Immune Medical Institute

Conditions & Keywords Data

Conditions:
Name
Cancer Disease
Keywords:
Name View
CD70 View
CAR-T View
cancer View
GD2 View